Combination therapy of tacrolimus, high doses of glucocorticosteroids, and cyclophosphamide against existing historical treatment for patients in severe conditions of interstitial lung diseases complicated with dermatomyositis: A retrospective analysis

The high-dose glucocorticosteroid (GC) treatment is the first choice for dermatomyositis complicated with interstitial lung disease (DM-ILD) but patients are resistant to the high-dose GC monotherapy. Besides, the high dose of GC, the secondary immunosuppressive agent(s) is necessary but there is co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lian, Li, Mu, Li, Yingchun, Wang, Kang, Xu, Shengqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276089/
https://www.ncbi.nlm.nih.gov/pubmed/35713427
http://dx.doi.org/10.1097/MD.0000000000029108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276089/
https://www.ncbi.nlm.nih.gov/pubmed/35713427
http://dx.doi.org/10.1097/MD.0000000000029108

Ejemplares similares